SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001104659-15-010467
Filing Date
2015-02-13
Accepted
2015-02-13 17:05:46
Documents
5
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q/A a15-4616_110qa.htm 10-Q/A 48817
2 EX-31.1 a15-4616_1ex31d1.htm EX-31.1 10627
3 EX-31.2 a15-4616_1ex31d2.htm EX-31.2 10628
4 EX-32.1 a15-4616_1ex32d1.htm EX-32.1 4244
5 EX-32.2 a15-4616_1ex32d2.htm EX-32.2 4649
  Complete submission text file 0001104659-15-010467.txt   79995
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q/A | Act: 34 | File No.: 000-55020 | Film No.: 15616078
SIC: 2834 Pharmaceutical Preparations